TTK Healthcare Q3 FY26 results, board changes, RPT policy update
TTKHLTCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.7 pts less than Nifty Microcap 250 and 3.3 pts less than its Diversified peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
TTK Healthcare posted Q3 FY26 revenue of Rs 20,357 lakhs versus Rs 20,474 lakhs year on year. PAT fell to Rs 1,053 lakhs versus Rs 1,673 lakhs due to a Rs 758 lakh exceptional charge for Labour Codes wage definition changes, versus a Rs 1,977 lakh property sale gain last year. 9M FY26 revenue rose about 4.6 percent to Rs 63,930 lakhs. Board committees were reconstituted from Feb 3, 2026 after Independent Director Mr N Ramesh Rajan's term ended. RPT policy updated per new SEBI rules. Auditor PKF Sridhar and Santhanam gave an unqualified review.
PAT decline driven by opposite exceptional items this year versus last, not core weakness. Underlying PBT before exceptional items is roughly steady.